Toll Brothers
TOL
Meritage Homes
MTH
Taylor Morrison Home
TMHC
D.R. Horton
DHI
KB Home
KBH
US Stock MarketDetailed Quotes
ETNB 89bio
- 7.350
- -0.050-0.68%
Close Jan 8 16:00 ET
- 7.360
- +0.010+0.14%
Post 19:26 ET
864.23MMarket Cap-2.48P/E (TTM)
7.560High7.271Low447.89KVolume7.350Open7.400Pre Close3.29MTurnover0.61%Turnover RatioLossP/E (Static)117.58MShares16.63052wk High2.29P/B543.34MFloat Cap6.43052wk Low--Dividend TTM73.92MShs Float47.253Historical High--Div YieldTTM3.91%Amplitude2.000Historical Low7.355Avg Price1Lot Size
89bio News
Cantor Fitzgerald Reiterates Overweight on 89bio, Maintains $29 Price Target
89bio Analyst Ratings
Cantor Fitzgerald Maintains 89bio(ETNB.US) With Buy Rating, Cuts Target Price to $29
89bio Strengthens Leadership Retention With New RSUs
Express News | 89Bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
89bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
89bio to Participate in the 7th Annual Evercore HealthCONx Conference
89Bio Inc. Reports Q3 2024 Financial Results
89bio Presents New Analyses Evaluating Pegozafermin and Potential Benefit of Non-Invasive Tests From the ENLIVEN Phase 2b Trial in MASH Patients at AASLD The Liver Meeting 2024
Express News | 89Bio Presents New Analyses Evaluating Pegozafermin and Potential Benefit of Non-Invasive Tests From the Enliven Phase 2B Trial in Mash Patients at Aasld the Liver Meeting® 2024
89bio (ETNB) Receives a Hold From Oppenheimer
Reported Earlier, 89bio Prices Upsized $125M Public Offering Of 11,455,882 Common Stock At $8.50/Share And Pre-Funded Warrants
89bio Drops 2%, Prices $125M Stock Offering
89bio Offering Is Expected to Close Around Nov. 14 >ETNB
89bio Prices $125.0M Upsized Public Offering of Stock, Warrants >ETNB
Express News | 89Bio Inc - Commences $100 Million Public Offering
89bio, Inc. Announces Proposed Underwritten Public Offering of Common Stock and Pre-Funded Warrants
Express News | 89Bio, Inc. Announces Proposed Underwritten Public Offering of Common Stock and Pre-Funded Warrants
Evercore Maintains 89bio(ETNB.US) With Buy Rating, Maintains Target Price $33
Analysts Offer Insights on Healthcare Companies: Janux Therapeutics Inc (JANX), 89bio (ETNB) and Ardent Health Partners, Inc. (ARDT)
Trending US Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries
Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.